Literature DB >> 1619973

[Massive gastrointestinal hemorrhage from a hepaticojejunostomy in pancreatogenic mesenteric vein thrombosis. Diagnosis and therapy].

M Kantartzis1, J Usmiani, J Lersmacher, K Damanakis, E Hoffmann.   

Abstract

Gastrointestinal hemorrhage in a patient with a biliodigestive anastomosis necessitates exclusion of a bleeding source in the region of the choledocho- or hepaticojejunal anastomosis. This cannot be achieved by endoscopic methods. The source of bleeding can sometimes, though rarely, be localised by performance of selective angiography during hemorrhage. Laparotomy with exploration of the anastomosis during such an episode is at the same time a diagnostic and a therapeutic intervention. The surgical procedure of choice is de-anastomosis, resection of the bypassed jejunal loop and formation of a hepatico-duodenostomy.

Entities:  

Mesh:

Year:  1992        PMID: 1619973     DOI: 10.1007/bf00184370

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  5 in total

1.  [Bleeding duodenal varices. Report of a case (author's transl)].

Authors:  M Buysschaert; D Lebrec; M Regensberg; H Nahum; J P Benhamou
Journal:  Arch Fr Mal App Dig       Date:  1976-09

2.  Chronic pancreatitis: a cause of biliary stricture.

Authors:  W J Schulte; A J LaPorta; R E Condon; G F Unger; J E Geenen; J J DeCosse
Journal:  Surgery       Date:  1977-09       Impact factor: 3.982

3.  [Superior mesenteric venous hypertension in chronic pancreatitis].

Authors:  M Ribet; P Quandalle; C L'Hermine; A Wurtz; J P Latreille
Journal:  Chirurgie       Date:  1971

Review 4.  Treatment of chronic pancreatitis complicated by obstruction of the common bile duct or duodenum.

Authors:  C F Frey; M Suzuki; S Isaji
Journal:  World J Surg       Date:  1990 Jan-Feb       Impact factor: 3.352

5.  Gastrointestinal hemorrhage from adhesion-related mesenteric varices.

Authors:  A C Moncure; A C Waltman; T J Vandersalm; R R Linton; F H Levine; W M Abbott
Journal:  Ann Surg       Date:  1976-01       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.